Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Animalcare GroupSTU:WQ7 77 3-Year RORE % is 21.72 as of Dec. 2025. GuruFocus rates STU:WQ7 with a GF Score™ of 77/100 and a GF Value™ of €2.88 (Fairly Valued). The stock has 7 warning signs investors should review. Among 945 Drug Manufacturers companies, Animalcare Group ranks better than 69.74% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Animalcare Group's 3-Year RORE % for the quarter that ended in Dec. 2025 was 21.72%.
The industry rank for Animalcare Group's 3-Year RORE % or its related term are showing as below:
STU:WQ7's 3-Year RORE % is ranked better than 69.74% of 945
companies
in the Drug Manufacturers industry
Industry Median: 3.09
vs STU:WQ7: 21.72
Animalcare Group (STU:WQ7) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Animalcare Group 3-Year RORE % Related Terms
Animalcare Group 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Animalcare Group's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:WQ7 vs ZTS, UTHR, VTRS: 3-Year RORE % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Animalcare Group's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Animalcare Group 3-Year RORE % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Animalcare Group's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Animalcare Group's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
Animalcare Group (STU:WQ7) has a 3-Year RORE % of 21.72 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Animalcare Group and its competitors. According to the industry distribution chart, Animalcare Group ranks #286 out of 945 companies in the Drug Manufacturers industry, placing it in the top 30.3%.
Is Animalcare Group's 3-Year RORE % too high?
Animalcare Group's current 3-Year RORE % is 21.72. The Drug Manufacturers industry median 3-Year RORE % is 3.09. Animalcare Group's value of 21.72 is 602.9% above this industry median. Based on the distribution chart, Animalcare Group ranks #286 out of 945 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Animalcare Group has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Animalcare Group's 3-Year RORE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Animalcare Group ranks #286 out of 945 companies for 3-Year RORE %. This puts Animalcare Group in the upper half of its industry. The industry median 3-Year RORE % is 3.09. Animalcare Group's value of 21.72 is 602.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Drug Manufacturers company?
The median 3-Year RORE % among Drug Manufacturers companies is 3.09, based on 945 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Animalcare Group's current 3-Year RORE % of 21.72 is 602.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Animalcare Group and its competitors. For the Drug Manufacturers industry, the median 3-Year RORE % is 3.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Animalcare Group's current 3-Year RORE % is 21.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Animalcare Group stock overvalued right now?
Based on GuruFocus' analysis, Animalcare Group (STU:WQ7) is currently considered Fairly Valued. The stock's GF Value™ is €2.88, compared to a current price of €3.00 — trading 4.2% above its estimated fair value. The current 3-Year RORE % is 21.72 and 602.9% above the Drug Manufacturers industry median of 3.09. Animalcare Group's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Animalcare Group (STU:WQ7), the current 3-Year RORE % is 21.72 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Animalcare Group (STU:WQ7) Overvalued in 2026?
Based on GuruFocus' analysis, Animalcare Group stock appears to be overvalued.
The current stock price of €3.00 is trading 4.2% above its estimated GF Value™ of €2.88.
GuruFocus considers Animalcare Group to be Fairly Valued.
Key valuation signals for STU:WQ7:
3-Year RORE %: 21.72
GF Value™: €2.88 vs. price of €3.00 (4.2% above fair value)
Industry Position: 602.9% above the Drug Manufacturers median (#286 of 945)
No single metric tells the full story. See the STU:WQ7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. The company operates in Animalcare Europe and Randlab segment. The company derives maximum revenue from the Animalcare Europe segment engaged in development and sale of veterinary pharmaceutical products in Europe and the European International Partners network. Geographically, the company derives maximum revenue from Europe region, followed by Asia-Pacific and other regions.
77GF Score
Get the complete analysis for STU:WQ7
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:WQ7 has been successfully added to your 
